Dysregulated expression or function of c-Myc is one of the most common abnormalities in human malignancy [16], such as breast cancer [17], colorectal cancer [18], [19], prostate cancer [20], [21], and hepatocellular carcinoma [22], [23]. This evidence concerns the gene MYC and prostate carcinoma.